BioDiscovery, Inc. – Medium

BioDiscovery, Inc.

BioDiscovery, Inc.

BioDiscovery releases Nexus Copy Number 9.0

El Segundo, CA, April, 4, 2017 — BioDiscovery’s Nexus Copy Number software is a leading solution for researchers across the globe for…

Apr 4, 2017

Apr 4, 2017

BioDiscovery, Inc.

Mosaic copy number aberrations in healthy individuals

Recently I was helping a customer with an unexpected mosaic event in a control sample. Since the sample origin was from blood, I had…

Jan 16, 2017

Jan 16, 2017

BioDiscovery, Inc.

Do you want to find causative mutation or prioritize variants for detailed analysis?

Even after filtering VCF files for low-quality and common variants there are about 10,000 sequence variants per genome with consequences…

Jan 16, 2017

Jan 16, 2017

BioDiscovery, Inc.

Patent Filed using Nexus Copy Number — for Canine Cancer Diagnosis

We’d like to congratulate Dr. Matthew Breen, Oscar J. Fletcher Distinguished Professor of Comparative Oncology Genetics, North Carolina…

Nov 15, 2016

Nov 15, 2016

BioDiscovery, Inc.

BioDiscovery to Announce release of NxClinical 3.0 at ASHG!

Latest Version of NxClinical Coming Soon

Oct 11, 2016

Oct 11, 2016

BioDiscovery, Inc.

Analyzing NGS Data For Copy Number Events

Next-generation sequencing (NGS) is mainly used to obtain sequence variants (SNVs), however there has been a movement in research and…

Sep 12, 2016

Analyzing NGS Data For Copy Number Events

Sep 12, 2016

BioDiscovery, Inc.

Integrated analysis of copy number, sequence variant and gene expression data in cancer cohort

Nexus Copy Number 8.0 analyzes DNA copy number variants and sequence variants, as well as the option to integrate associated RNA expression…

Aug 5, 2016

Aug 5, 2016

BioDiscovery, Inc.

Comparison of CNV Detection Between Whole-Exome Sequencing and Microarray Platforms in Cancer…

Copy number variants have been implicated as drivers in many different tumor types. The platform of choice to detect genome-wide CNVs has…

Jul 8, 2016

Comparison of CNV Detection Between Whole-Exome Sequencing and Microarray Platforms in Cancer…

Jul 8, 2016

BioDiscovery, Inc.

Integrated analysis of copy number, sequence variant and gene expression data in cancer cohort

Join us on Thursday, July 21, 2016 for an Educational Webinar

Jul 8, 2016

Jul 8, 2016

BioDiscovery, Inc.

BioDiscovery, Inc.

We develop, market, and sell advanced software solutions for the analysis of data from high-throughput microarray and next-generation sequencing technologies.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams